Kaster
Founded 2022 · 10 employees on LinkedIn · 1 known investors
Kaster Technology builds prescriptive AI software (AIM | Pace) that generates and continuously adjusts GMP-compliant production schedules for pharmaceutical manufacturers, modeling constraints like changeovers, equipment, labor, and lab/QA release timings. It integrates with existing ERP/MES systems to increase capacity and throughput for drug manufacturers producing sterile injectables, oral solid dosage, and biologics.
Also known as Kaster Technologies · Kaster Technology
Investors · 1
Company profile
researched Aug 2026Kaster Technology (Kaster Technologies) develops prescriptive AI software for short-term production planning at large-scale pharmaceutical manufacturing sites. Its product, AIM | Pace, generates executable daily production plans that model plant constraints including changeovers, campaign sequencing, line availability, labor, utilities and shared equipment, and continuously adjusts those plans down to the minute as real-world events such as delays, holds or lab release timings occur.
The software is positioned against the operational problems drug makers face with complex routings, thousands of constraints, disconnected Excel and ERP workflows, and lab/QC release schedules that are out of sync with production, all of which contribute to on-time-in-full (OTIF) delays. Functional areas include regulatory-aware scheduling that respects GMP rules and equipment constraints, granular-level planning, shared-resource orchestration across rooms, lines, utilities and people, lab and QA release synchronization, energy usage optimization, and changeover and campaign optimization. Kaster states the system is designed for sterile injectables, oral solid dosage and biologics production.
Business model
Kaster sells software to pharmaceutical manufacturers, positioning engagements as innovation partnerships in which it co-develops features alongside customers' planners, operators and quality teams and maintains an applied research pipeline that converts frontline manufacturing challenges into deployable product features.
Traction
Kaster reports its prescriptive AI has been applied across multiple pharmaceutical plants, citing roughly 10% additional production capacity unlocked without capital expenditure and 20% more efficient workflows validated at what it describes as Canada's largest sterile injectable site.
Latest developments
The company indicates an additional customer case study is planned for 2026.
▸Full profile — market position, technology, go-to-market, geography
Market position
Kaster contrasts its approach with legacy scheduling tools and spreadsheet/ERP-based planning, emphasizing built-in GMP and pharmaceutical domain expertise, minute-level continuous rescheduling, synchronization of lab and QA release timings with production, and deployment without replacing incumbent ERP or MES systems or adding equipment and shifts.
Technology
AIM | Pace is described as proprietary prescriptive AI purpose-built for high-volume pharmaceutical production. It models plant constraints to produce GMP-compliant, audit-ready production sequences and operates in a closed loop, re-optimizing schedules automatically in response to real-time events. Kaster emphasizes low-friction integration that works alongside existing ERP and MES systems rather than replacing them.
Go-to-market
Direct sales through the company website, which offers a 15-minute demo booking, supported by customer case studies (with a further case study indicated for 2026) and a co-development partnership approach with manufacturing customers.
Large-scale pharmaceutical manufacturers, including sites producing sterile injectables, oral solid dosage forms and biologics, and specifically the production planning, operations and quality functions within those plants.
Geography
Canada-based, with deployments referenced at Canadian pharmaceutical manufacturing sites and a stated aim of supporting medicine supply internationally.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
▸Research sources · 1
primary sources listed
- Kasterkaster.ca · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Kaster do?
- Kaster builds prescriptive AI scheduling software for short-term production planning at pharmaceutical manufacturing plants.
- Who are Kaster's investors?
- Kaster's investors include Graphite Ventures.